Reading KIDS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KIDS free→Reading KIDS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KIDS free→QuarterlyIQ Insights · KIDS
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(9.8) + peer(0.2*2.4) + term(0.0) → 3.92% (capped ±15.0)
in 48 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On April 30, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended March 31, 2026 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended March 31, 2026, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, includi…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On February 26, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter and year ended December 31, 2025, providing management's projection of 2026 revenue, EBITDA and break-even cash flow, and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter and year ended December 31, 2025, and other financial data) is furnis…
of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The financial information set forth in this Form 8-K reflects the Company's current preliminary net revenue and free cash flow estimates, is subject to the completi…
Results of Operations and Financial Condition. On October 28, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended September 30, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended September 30, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.0…
of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The financial information set forth in this Form 8-K reflects the Company's current preliminary net revenue estimates, is subject to the completion of its audit pro…
Results of Operations and Financial Condition. On August 5, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended June 30, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended June 30, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including…
Results of Operations and Financial Condition. On May 7, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended March 31, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended March 31, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including…
Results of Operations and Financial Condition. On March 4, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter and year ended December 31, 2024 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter and year ended December 31, 2024, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in…